about
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsGuidelines for the use and interpretation of assays for monitoring autophagyRegulation of the Host Antiviral State by Intercellular CommunicationsAn Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesConstruction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimerasThe autophagy machinery is required to initiate hepatitis C virus replicationAmphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral EntryHuman broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virusA multi-colour/multi-affinity marker set to visualize phosphoinositide dynamics in Arabidopsis.Hepatitis C virus is primed by CD81 protein for low pH-dependent fusionFunctional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse ModelScavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.Cell-Cell Sensing of Viral Infection by Plasmacytoid Dendritic CellsCharacterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.Detection of neutralizing antibodies with HCV pseudoparticles (HCVpp).The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry.Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses.Plasmacytoid Dendritic Cells and Infected Cells Form an Interferogenic Synapse Required for Antiviral ResponsesSensing of cell-associated HTLV by plasmacytoid dendritic cells is regulated by dense β-galactoside glycosylation[Modulation of permissiveness and antiviral response against hepatitis C virus by interferon lambda-associated polymorphism]Differential Roles of Lipin1 and Lipin2 in the Hepatitis C Virus Replication Cycle
P50
Q21089621-93164A56-5EFE-4174-A7CB-41F7D1410A14Q21996341-1694DDC5-568D-4991-83EE-CDCBA616EAAAQ26795744-4E364E48-51DC-4277-9AC3-EC7E70FB0DDEQ27469837-826386FC-4CBC-4931-AA40-754682AA74B4Q27473179-CDB3B0C7-D612-40E4-BFDA-19093C621396Q27489377-26CB7B1A-9767-4BFA-AD64-ACBC7E80DB98Q27490785-29A5ABA0-E5ED-4B95-A381-513F1B4F1ED3Q34228030-E0E20F51-A9F3-4F44-AE28-60A9C148ECC3Q35023800-DB2F7291-A189-4559-A40C-98278B3338DCQ35182834-153BFE68-B36A-4F05-A775-93A323D813A6Q36281615-A64ED123-D429-4319-801D-C508143F963AQ37864742-F003BFCD-1D80-4985-A392-10D9D7CFD762Q38727055-31E37D48-8D7E-44D1-9446-6F29DA68F925Q38949057-3273055F-7B55-41E0-B29A-2289CC20A22DQ39318833-A1A19340-5947-46A1-B96F-C605B681D6F2Q39916872-0B002036-7D7E-41A2-A1AB-E97527DA89DBQ40087031-89F4AB8B-5BB0-4D97-9324-717545D4A362Q41928655-A6B097A3-B0E0-4A18-87CC-FB576CF7651AQ42980990-2098CEC9-04FB-4009-8D00-C9405D929581Q42999970-7743FEFF-BB3A-4243-9182-29802AF8E112Q43001835-5C60546B-BFBB-45A1-AECD-C5AA70132C43Q55278680-F50B388E-57F9-4A96-AD82-5210F02D730CQ63248431-F1D9151F-0882-4760-9695-F0D03FDF16F7Q63707041-B3F3F33F-7E25-4F8A-9A9E-71422C74826FQ86394090-3E0EA1C2-576D-42D7-9FDE-90C7C175A6B9Q91376999-7E13C0F5-8223-4169-9C22-A87A2158517C
P50
description
investigador
@es
researcher
@en
name
Marlène Dreux
@en
type
label
Marlène Dreux
@en
prefLabel
Marlène Dreux
@en
P31
P496
0000-0002-6607-4796